Gain Therapeutics plans phase 2 Parkinson’s study in Q3 2026

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Prologis raises 2026 outlook again as record leasing boosts second-quarter profit Hisse Senetleri 0 1
A Earnings call transcript: Mips jumps on strong Q2 2026 growth and margin gains Hisse Senetleri 0 2
A Kongsberg Automotive shares gain after Q2 swings to profit on restructuring Hisse Senetleri 0 2
A Bergman & Beving Q1 2026/27 slides: 26th straight profit gain Hisse Senetleri 0 1
A Earnings call transcript: AddLife’s Q2 2026 margin gains lift shares 41% Hisse Senetleri 0 2
A Iovance Biotherapeutics’ SWOT analysis: stock gains momentum on melanoma data Hisse Senetleri 0 11
A PTC Therapeutics’ SWOT analysis: stock gains on rare disease drug launch Hisse Senetleri 0 12
A Plus Therapeutics stock gains after FDA orphan drug nod Hisse Senetleri 0 25

Benzer konular

Üst